Cardiac, Endocrine, and Immune System Management
At a Glance
Proximal 18q deletion syndrome affects multiple body systems, requiring proactive medical management. Key priorities include screening for structural heart defects linked to the GATA6 gene, treating growth hormone and thyroid deficiencies, and managing immune system weaknesses.
While the neurological aspects of Proximal 18q Deletion Syndrome often get the most attention, the syndrome also affects several internal systems that require careful medical oversight. Because the syndrome is a spectrum, you or your child may face challenges in some of these areas but not others [1]. Proactive screening allows the medical team to manage these physical health needs before they become serious issues.
Cardiac Health: The Heart
Structural heart differences are a critical risk in Proximal 18q deletions, especially if the GATA6 gene (located at 18q11.2) is deleted [1]. These defects are often present at birth and require monitoring or intervention by a cardiologist [1][2].
- Conotruncal Defects: Driven primarily by GATA6 haploinsufficiency, these are a group of heart defects that affect the “outflow tracts” of the heart—the large vessels that carry blood out to the body and lungs [1].
- Subaortic Stenosis: This is a narrowing of the area just below the aortic valve, which can make it harder for the heart to pump blood to the rest of the body [2].
- Aortic Regurgitation: This occurs when the heart’s aortic valve doesn’t close tightly, allowing some blood to leak backward [2].
Endocrine Management: Hormones and Growth
The endocrine system regulates growth, metabolism, and energy. Many individuals with 18q- have hormone-related challenges that are very responsive to treatment [3][4].
- Growth Hormone Deficiency: Short stature is very common due to low growth hormone levels. Recombinant human growth hormone (rhGH) therapy has been shown to be highly effective and safe, often leading to significant “catch-up growth” [5][4].
- Thyroid Function: Both hypothyroidism (underactive thyroid) and autoimmune thyroiditis are frequently reported [3][6]. Regular blood tests to monitor thyroid levels are standard because these issues can severely affect energy levels and cognitive function.
- Type 1 Diabetes: There is a documented association between 18q deletions and an increased risk of developing Type 1 Diabetes (an autoimmune condition where the body does not produce enough insulin) [3]. While it is less common than growth hormone deficiency or thyroid issues, it remains an important consideration for ongoing monitoring.
Immune System: Fighting Infection
The immune system in Proximal 18q- can sometimes be “weakened” or “confused,” manifesting in two primary ways [7]:
- Immunodeficiency: Many patients have humoral immunodeficiency (such as hypogammaglobulinemia), meaning they don’t produce enough antibodies (like IgA or IgG) to fight off germs [7][3]. This can lead to frequent ear infections (otitis media) or respiratory issues [2].
- Autoimmunity: Sometimes the immune system mistakenly attacks the body’s own tissues, which explains why conditions like thyroiditis and Type 1 Diabetes can occur [3].
Dental and Palate Considerations
Craniofacial and oral health are also part of the 18q- profile.
- Cleft Palate: Some individuals are born with an opening in the roof of the mouth (cleft palate), which can affect feeding and speech early in life [8].
- Dental Anomalies: Reports show unique dental needs, sometimes requiring extractions or specialized care to improve speech and chewing [9]. Early and regular visits to a dentist familiar with genetic syndromes are highly recommended.
Regular screenings for these physical systems ensure that the body is supported and healthy as you or your child grows [7][10].
Common questions in this guide
What heart problems are associated with proximal 18q deletion?
Can proximal 18q deletion affect my child's growth?
Why do patients with 18q- syndrome get frequent infections?
What endocrine issues should be monitored in 18q deletion syndrome?
Does proximal 18q deletion cause dental or palate issues?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has an echocardiogram been performed to check for subaortic stenosis or conotruncal heart defects driven by the GATA6 gene?
- 2.Should we schedule a 'bone age' X-ray or growth hormone stimulation test to see if rhGH therapy is appropriate?
- 3.What specific blood tests should be run to monitor for thyroid issues?
- 4.Could you check immunoglobulin levels (IgG, IgA, IgM) to see if extra protection from common infections is needed?
- 5.Are there any specific dental or palate differences that could interfere with speech or feeding?
- 6.How often should we repeat the immune and endocrine screenings over time?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
Clinical delineation of 18q11-q12 microdeletion: Intellectual disability, speech and behavioral disorders, and conotruncal heart defects.
Rojnueangnit K, Charalsawadi C, Thammachote W, et al.
Molecular genetics & genomic medicine 2019; (7(9)):e896 doi:10.1002/mgg3.896.
PMID: 31390163 - 2
18q Deletion Syndrome-Associated Schizophrenia: A Case Report.
Colijn MA, Crockford DN
Neuropsychobiology 2024; (83(3-4)):179-182 doi:10.1159/000538693.
PMID: 38684151 - 3
Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes.
Hogendorf A, Szadkowska A, Michalak A, et al.
International journal of immunopathology and pharmacology 2021; (35()):20587384211039400 doi:10.1177/20587384211039400.
PMID: 34514903 - 4
Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
Liu S, Chen M, Yang H, et al.
Frontiers in endocrinology 2021; (12()):776835 doi:10.3389/fendo.2021.776835.
PMID: 34956087 - 5
An overview of growth hormone therapy in pediatric cases documented in the Kabi International Growth Study (Pfizer International Growth Database).
Geffner ME, Ranke MB, Wajnrajch MP,
Annals of pediatric endocrinology & metabolism 2024; (29(1)):3-11 doi:10.6065/apem.2346206.103.
PMID: 38461800 - 6
Dystonic tremor and blepharospasm in a patient with deletion of 18q.
Tereshko Y, Belgrado E, Lettieri C, et al.
Clinical neurology and neurosurgery 2023; (224()):107549 doi:10.1016/j.clineuro.2022.107549.
PMID: 36502650 - 7
18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency.
Hashiguchi S, Tomomasa D, Nishikawa T, et al.
Journal of clinical immunology 2024; (44(7)):154 doi:10.1007/s10875-024-01751-4.
PMID: 38896123 - 8
Case report: genetic analysis of a child with 18q deletion syndrome and developmental dysplasia of the hip.
Yu S, Wang C, Lei K, et al.
BMC medical genomics 2022; (15(1)):199 doi:10.1186/s12920-022-01345-2.
PMID: 36123715 - 9
Oral Care in a Patient with Long Arm Deletion Syndrome of Chromosome 18: A Narrative Review and Case Presentation.
Pisano M, Sangiovanni G, D'Ambrosio F, et al.
The American journal of case reports 2022; (23()):e936142 doi:10.12659/AJCR.936142.
PMID: 35746851 - 10
Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study.
Rhie YJ, Yoo JH, Choi JH, et al.
PloS one 2019; (14(5)):e0216927 doi:10.1371/journal.pone.0216927.
PMID: 31095622
This page provides educational information about physical health management in proximal 18q deletion syndrome. Always consult your medical genetics team, cardiologist, or endocrinologist for personalized screening and treatment plans.
Get notified when new evidence is published on Proximal chromosome 18q deletion syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.